Tag: Lupus
Hydroxychloroquine Level Tied to Thrombosis Risk in Lupus
Rate of thrombotic events lower for patients with mean HCQ blood levels >1,068 versus <648 ng/mL
Two-Thirds of Lupus Patients Likely to Take COVID-19 Vaccine
However, national survey uncovered racial differences in uptake, safety concerns
Physical Activity, Sleep Profiles Vary in Adults With Arthritis
Balanced activity profile linked to weaker work-related sitting habit, stronger outside walking habit
Some Lupus Erythematosus Cases Tied to Drug Exposure
Cases found for both cutaneous and systemic lupus, but some previous reports due to protopathic bias
Risk for COVID-19 Hospitalization Follows Usual Pattern in Lupus
Similar to the general population, predictors of hospitalization include race, comorbidity, and BMI
One-Third of Lupus Patients Have Trouble Refilling Hydroxychloroquine
Patients report lack of availability at usual pharmacy, waiting weeks for refills, only getting partial refills
Antimalarials May Cut Risk for Type 2 Diabetes in Lupus Patients
T2DM risk reduced by 39 percent for those with high adherence to antimalarial therapy for managing lupus
S. aureus Colonization Increased in Skin Lesions in Lupus Patients
Repression of barrier gene expression, increased S. aureus-binding integrins in SLE keratinocytes found
Peripheral Nervous System Events Not Common in Lupus
History of neuropathy, older age at diagnosis among factors tied to longer time to resolution of PNS events
Anifrolumab Improves Response at 52 Weeks in Lupus
Rate of composite response showing reduced disease activity higher with anifrolumab versus placebo
